Writer and Consultant
Founder and Managing Partner, City Hill Ventures
Managing Director, D.E. Shaw and Co., L.P.
Co-Founder and CEO, DUO Security
Professor, Biochemistry and Biophysics, UCSF
Senior Partner, Bessemer Venture Partners
Managing Director, Versant Ventures
President and CEO, Complete Genomics
|
|
Omeros, a Seattle-based drug developer, said it has received a $465,000 grant from the Michael J. Fox Foundation for Parkinson’s Research. The grant will pay for research of a new target on brain cells discovered by Omeros scientists, which has been linked to movement disorders like Parkinson’s and Restless Leg Syndrome.
Boston · 6/19/13
9:00 am
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
